Also trades as: HZNOF (OTC) · $vol 0M
DXT.TO TSX
Dexterra Group Inc.
1W: +6.4%
1M: +24.9%
3M: +23.4%
YTD: +26.0%
1Y: +71.3%
3Y: +232.6%
5Y: +198.9%
C$17.41 ($12.22)
+0.46 (+2.71%)
Weekly Expected Move ±4.4%
C$16
C$16
C$17
C$18
C$19
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$1.0B
+3.8% ▲
5Y CAGR: +16.9%
Gross Profit
$144M
-9.8% ▼
5Y CAGR: +8.0%
Operating Income
$65M
-3.6% ▼
5Y CAGR: +5.0%
Net Income
$41M
+103.9% ▲
5Y CAGR: -8.8%
EPS (Diluted)
$0.64
+106.5% ▲
5Y CAGR: -12.4%
EBITDA
$107M
+5.0% ▲
5Y CAGR: +0.2%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $733M | $972M | $1.1B | $1.0B | $1.0B |
| YoY Growth | +53.5% | +32.5% | +15.0% | -10.2% | +3.8% |
| Cost of Revenue | $623M | $881M | $787M | $843M | $897M |
| Gross Profit | $111M | $91M | $141M | $160M | $144M |
| Gross Margin | 15.1% | 9.3% | 12.6% | 16.0% | 13.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $37M | $42M | $44M | $58M | $80M |
| Operating Expenses | $75M | $81M | $82M | $93M | $80M |
| Operating Income | $36M | $10M | $59M | $67M | $65M |
| Operating Margin | 4.9% | 1.0% | 5.3% | 6.7% | 6.2% |
| Interest Expense | $5M | $9M | $13M | $13M | $11M |
| Income Before Tax | $33M | $3M | $48M | $54M | $55M |
| Tax Expense | $9M | -$495K | $12M | $16M | $14M |
| Net Income | $24M | $3M | $27M | $20M | $41M |
| Net Margin | 3.3% | 0.4% | 2.4% | 2.0% | 3.9% |
| EPS (Diluted) | $0.37 | $0.05 | $0.41 | $0.31 | $0.64 |
| EBITDA | $74M | $63M | $94M | $102M | $107M |
| Shares Outstanding | 65M | 65M | 65M | 64M | 63M |